Salick Health Care has expanded its New York City presence with a contract to manage six oncologists affiliated with New York University Medical Center.
As part of the management agreement, Salick announced last week that it will build a 20,000-square-foot cancer-care facility for ambulatory patients near the university's main campus.
The Los Angeles-based company will spend $6 million to $8 million to renovate the building, said John Macdonald, M.D., Salick's national director of physician organizations. It's expected to open by Aug 1.
Salick is a subsidiary of Zeneca Group, a London-based pharmaceutical company, maker of the anti-cancer drug Tamoxifen. But Salick said there is nothing in its management contracts that requires physicians to use those drugs.
The NYU oncologists will continue their research, teaching and administrative activities at NYU's School of Medicine and the medical center's cancer center. Salick wouldn't disclose how much physicians are paying for management services.
The NYU doctor deal is the first in what the company hopes will be a series of accords with oncologists in the region.
By developing networks of physicians, the company hopes to "be a force in managed-care contracting," he added.
Salick established a base in the market with its cancer center at New York's Saint Vincents Hospital and Medical Center. Now it faces a new competitor: the company's own founder, Bernard Salick, M.D.
Salick's new company, Beverly Hills-based Bentley Health Care, has a joint-venture agreement with Montefiore Medical Center in the Bronx to open a chain of cancer and AIDS clinics.